Baker Ellis Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Baker Ellis Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,705	Closed	-$511K	–	240
2019 Q3	$511K	Sell	6,705 -250	-4%	-$20.8K	0.14%	118
2019 Q2	$610K	Buy	6,955 +450	+7%	+$38.4K	0.16%	107
2019 Q1	$589K	Sell	6,505 -50	-0.8%	-$4.25K	0.16%	111
2018 Q4	$470K	Buy	6,555 +3,950	+152%	+$318K	0.14%	119
2018 Q3	$250K	Buy	+2,605	New	+$253K	0.06%	169

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Baker Ellis Asset Management's XBI Position: Q4 2019 in Review

Baker Ellis Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2019, closing a stake of 6,705 shares — an estimated $511K sold.

Baker Ellis Asset Management first reported a position in XBI in Q3 2018 and held it in 5 quarters. The position peaked at $610K in Q2 2019. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

Baker Ellis Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2019 after selling out during the quarter.
Baker Ellis Asset Management sold 6,705 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $511K.
Baker Ellis Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 5 quarters.
Baker Ellis Asset Management's State Street SPDR S&P Biotech ETF position peaked at $610K in Q2 2019.
474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on Baker Ellis Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.